Mechanism of action<unk>  binds selectively to some of the sphingosine-1-phosphate receptor forms—including sphingosine-1-phosphate receptor 1—found on lymphocytes and other cell types. This binding inhibits the migration of the lymphocytes to the location of the inflammation (e.g. in MS).<unk>  may be very similar to fingolimod but preventing lymphopenia, one of its main side effects, by preventing egress of lymphocytes from lymph nodes.<unk>  may be more selective in the particular sphingosine-1-phosphate receptors (five in number) that it modulates. It is selective for the -1 and -5 SIP receptors.
Siponimod
Ozanimod
Ponesimod
Calaspargase pegol
Belinostat
Inotersen
Nusinersen
Vosoritide